Nippon Shinyaku Co., Ltd. (4516.T)
JPY 3735.0
(0.89%)
JPY 3735.0
(0.89%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 97.01 Billion JPY | 10.0% |
| 2022 | 88.19 Billion JPY | 1.03% |
| 2021 | 87.29 Billion JPY | 21.36% |
| 2020 | 71.93 Billion JPY | 13.31% |
| 2019 | 63.48 Billion JPY | -0.44% |
| 2018 | 63.76 Billion JPY | 16.96% |
| 2017 | 54.51 Billion JPY | 1.06% |
| 2016 | 53.94 Billion JPY | 34.22% |
| 2015 | 40.19 Billion JPY | 3.68% |
| 2014 | 38.76 Billion JPY | 3.42% |
| 2013 | 37.48 Billion JPY | 6.59% |
| 2012 | 35.16 Billion JPY | 1.63% |
| 2011 | 34.6 Billion JPY | 3.81% |
| 2010 | 33.33 Billion JPY | -1.78% |
| 2009 | 33.93 Billion JPY | -0.65% |
| 2008 | 34.15 Billion JPY | 6.5% |
| 2007 | 32.07 Billion JPY | 2.78% |
| 2006 | 31.2 Billion JPY | 1.82% |
| 2005 | 30.64 Billion JPY | -1.47% |
| 2004 | 31.1 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 26.49 Billion JPY | 10.83% |
| 2023 Q2 | 23.94 Billion JPY | -0.44% |
| 2023 Q1 | 24.05 Billion JPY | 15.45% |
| 2023 FY | 97.01 Billion JPY | 10.0% |
| 2023 Q4 | 23.9 Billion JPY | -8.48% |
| 2023 Q3 | 26.12 Billion JPY | 9.09% |
| 2022 Q3 | 24.21 Billion JPY | 12.89% |
| 2022 Q2 | 21.45 Billion JPY | -1.09% |
| 2022 Q1 | 21.69 Billion JPY | 14.61% |
| 2022 FY | 88.19 Billion JPY | 1.03% |
| 2022 Q4 | 20.83 Billion JPY | -13.98% |
| 2021 FY | 87.29 Billion JPY | 21.36% |
| 2021 Q3 | 21.38 Billion JPY | 11.34% |
| 2021 Q2 | 19.2 Billion JPY | -31.21% |
| 2021 Q1 | 27.92 Billion JPY | 53.1% |
| 2021 Q4 | 18.92 Billion JPY | -11.51% |
| 2020 FY | 71.93 Billion JPY | 13.31% |
| 2020 Q1 | 17.09 Billion JPY | 6.5% |
| 2020 Q3 | 20.86 Billion JPY | 32.68% |
| 2020 Q4 | 18.24 Billion JPY | -12.59% |
| 2020 Q2 | 15.72 Billion JPY | -8.0% |
| 2019 Q2 | 14.98 Billion JPY | -6.85% |
| 2019 Q4 | 16.05 Billion JPY | -1.82% |
| 2019 FY | 63.48 Billion JPY | -0.44% |
| 2019 Q3 | 16.35 Billion JPY | 9.08% |
| 2019 Q1 | 16.09 Billion JPY | 1.61% |
| 2018 Q4 | 15.83 Billion JPY | -18.86% |
| 2018 FY | 63.76 Billion JPY | 16.96% |
| 2018 Q1 | 14.57 Billion JPY | 20.11% |
| 2018 Q2 | 13.83 Billion JPY | -5.12% |
| 2018 Q3 | 19.51 Billion JPY | 41.11% |
| 2017 Q2 | 14.1 Billion JPY | 7.74% |
| 2017 Q1 | 13.08 Billion JPY | 12.75% |
| 2017 FY | 54.51 Billion JPY | 1.06% |
| 2017 Q4 | 12.13 Billion JPY | -20.13% |
| 2017 Q3 | 15.19 Billion JPY | 7.77% |
| 2016 FY | 53.94 Billion JPY | 34.22% |
| 2016 Q1 | 12.6 Billion JPY | 29.73% |
| 2016 Q4 | 11.6 Billion JPY | -40.96% |
| 2016 Q3 | 19.66 Billion JPY | 95.16% |
| 2016 Q2 | 10.07 Billion JPY | -20.08% |
| 2015 FY | 40.19 Billion JPY | 3.68% |
| 2015 Q4 | 9.71 Billion JPY | -23.09% |
| 2015 Q3 | 12.63 Billion JPY | 40.27% |
| 2015 Q2 | 9 Billion JPY | 1.9% |
| 2015 Q1 | 8.83 Billion JPY | -12.45% |
| 2014 FY | 38.76 Billion JPY | 3.42% |
| 2014 Q1 | 8.42 Billion JPY | -16.97% |
| 2014 Q2 | 8.51 Billion JPY | 1.06% |
| 2014 Q3 | 11.72 Billion JPY | 37.75% |
| 2014 Q4 | 10.09 Billion JPY | -13.93% |
| 2013 Q3 | 10.01 Billion JPY | 13.48% |
| 2013 FY | 37.48 Billion JPY | 6.59% |
| 2013 Q1 | 8.5 Billion JPY | -6.79% |
| 2013 Q2 | 8.82 Billion JPY | 3.75% |
| 2013 Q4 | 10.14 Billion JPY | 1.37% |
| 2012 Q4 | 9.12 Billion JPY | -3.45% |
| 2012 Q1 | 8.44 Billion JPY | 1.34% |
| 2012 Q3 | 9.44 Billion JPY | 15.9% |
| 2012 Q2 | 8.15 Billion JPY | -3.45% |
| 2012 FY | 35.16 Billion JPY | 1.63% |
| 2011 Q2 | 8.2 Billion JPY | -3.7% |
| 2011 Q3 | 9.53 Billion JPY | 16.19% |
| 2011 Q4 | 8.33 Billion JPY | -12.65% |
| 2011 FY | 34.6 Billion JPY | 3.81% |
| 2011 Q1 | 8.52 Billion JPY | -0.99% |
| 2010 Q3 | 8.61 Billion JPY | 14.48% |
| 2010 Q2 | 7.52 Billion JPY | -12.4% |
| 2010 Q1 | 8.58 Billion JPY | 25.68% |
| 2010 Q4 | 8.6 Billion JPY | -0.03% |
| 2010 FY | 33.33 Billion JPY | -1.78% |
| 2009 Q4 | 6.83 Billion JPY | -37.59% |
| 2009 FY | 33.93 Billion JPY | -0.65% |
| 2009 Q3 | 10.94 Billion JPY | 43.88% |
| 2009 Q2 | 7.6 Billion JPY | -10.96% |
| 2009 Q1 | 8.54 Billion JPY | 18.28% |
| 2008 Q2 | 7.34 Billion JPY | 0.0% |
| 2008 FY | 34.15 Billion JPY | 6.5% |
| 2008 Q3 | 9.25 Billion JPY | 26.01% |
| 2008 Q4 | 7.22 Billion JPY | -21.96% |
| 2007 FY | 32.07 Billion JPY | 2.78% |
| 2006 FY | 31.2 Billion JPY | 1.82% |
| 2005 FY | 30.64 Billion JPY | -1.47% |
| 2004 FY | 31.1 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 48.75 Billion JPY | -99.001% |
| Takeda Pharmaceutical Company Limited | 2184.96 Billion JPY | 95.56% |
| Sumitomo Pharma Co., Ltd. | 187.98 Billion JPY | 48.39% |
| Shionogi & Co., Ltd. | 369.08 Billion JPY | 73.714% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.54 Billion JPY | -2639.937% |
| Kaken Pharmaceutical Co., Ltd. | 38.22 Billion JPY | -153.825% |
| Eisai Co., Ltd. | 586.41 Billion JPY | 83.456% |
| Morishita Jintan Co., Ltd. | 5.99 Billion JPY | -1517.489% |
| Hisamitsu Pharmaceutical Co., Inc. | 78.97 Billion JPY | -22.851% |
| Mochida Pharmaceutical Co., Ltd. | 52.07 Billion JPY | -86.32% |
| Fuso Pharmaceutical Industries,Ltd. | 13.51 Billion JPY | -617.741% |
| Nippon Chemiphar Co., Ltd. | 7.73 Billion JPY | -1153.774% |
| Tsumura & Co. | 68.81 Billion JPY | -40.978% |
| Kissei Pharmaceutical Co., Ltd. | 37.34 Billion JPY | -159.814% |
| Torii Pharmaceutical Co., Ltd. | 24.79 Billion JPY | -291.324% |
| Towa Pharmaceutical Co., Ltd. | 81.38 Billion JPY | -19.21% |
| Fuji Pharma Co., Ltd. | 16.51 Billion JPY | -487.448% |
| Zeria Pharmaceutical Co., Ltd. | 50.18 Billion JPY | -93.333% |
| KYORIN Holdings, Inc. | 51.4 Billion JPY | -88.749% |
| Taiko Pharmaceutical Co.,Ltd. | 1.07 Billion JPY | -8891.381% |
| Daito Pharmaceutical Co.,Ltd. | 9.83 Billion JPY | -886.045% |
| SymBio Pharmaceuticals Limited | 4.41 Billion JPY | -2099.426% |
| MedRx Co., Ltd | 26 Million JPY | -373042.308% |
| Mizuho Medy Co.,Ltd. | 8.02 Billion JPY | -1108.827% |
| Solasia Pharma K.K. | 337 Million JPY | -28688.427% |
| Modalis Therapeutics Corporation | -731 Thousand JPY | 13271919.425% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 30.66 Billion JPY | -216.377% |
| Sawai Group Holdings Co., Ltd. | 54.31 Billion JPY | -78.606% |
| Cyfuse Biomedical K.K. | 37.74 Million JPY | -256939.529% |
| Toho Holdings Co., Ltd. | 112.98 Billion JPY | 14.133% |
| Koa Shoji Holdings Co.,Ltd. | 6.63 Billion JPY | -1361.187% |